June 13, 2020 Bio/Pharma/CRO PAI Top-10

Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020

Basel, 13 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual... Read more

June 8, 2020 PAI Top-10

Takara Bio Group’s Formulation of Long-Term Management Plan FY2026 and Medium-Term Management Plan FY2023

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

May 28, 2020 PAI Top-10

Notice of the 18th Annual General Meeting of Shareholders

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

May 27, 2020 PAI Top-10

Peering Inside the Solidification Process of Metals

X-ray tomography and 3D EBSD help researchers better understand the formation of complex microstructures through crystallization The complex pathway by which metals and alloys form solids via crystallization is still not fully understood by the scientists and engineers who have studied these materials for decades. Dr. Ashwin Shahani and his group at the University of... Read more

May 19, 2020 Atomic Spectroscopy Microscopy PAI Top-10

【Delayed】Consolidated Financial Statements for the Year Ended March 31, 2020 FY2020 (April 1, 2019 -March 31, 2020)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

May 18, 2020 Acad, Gov/Utilities Lab Top-10 PAI Top-10

Thermo Fisher Scientific's Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection

Thermo Fisher Scientific’s Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection WALTHAM, Mass., May 18, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has received a contract from the U.S. government to provide highly specialized viral transport... Read more

May 14, 2020 Clinical Research/Diagn. PAI Top-10

Roche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCO

Phase II CITYSCAPE trial shows promising results adding tiragolumab to Tecentriq in people with PD-L1-positive metastatic non-small cell lung cancer Full results will be presented in an oral abstract session at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO) Basel, 14 May 2020 – Roche (SIX: RO, ROG; OTCQX:... Read more

May 7, 2020 PAI Top-10

BD Announces Results For 2020 Second Fiscal Quarter; Withdraws Fiscal Year 2020 Guidance Due To COVID-19 Pandemic

FRANKLIN LAKES, N.J., May 7, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.253 billion for the second fiscal quarter ended March 31, 2020.  This represents an increase of 1.4 percent as reported over the prior-year period, or 2.4 percent on a currency-neutral... Read more

May 6, 2020 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Reports First Quarter 2020 Results

WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended April 3, 2020.  All results in this release reflect only continuing operations unless otherwise noted. For the first quarter 2020, net earnings were $595.1 million, or $0.81 per diluted common share.  Non-GAAP adjusted diluted net earnings... Read more